Paclitaxel/Encequidar mesylate | m-entrepreneurship.com

Product Name :
Paclitaxel/Encequidar mesylate

Search keywords :
Doxorubicin

drugId :
null

Target Vo:
Tubulin

Target Vo Short Name :
Tubulin

Moa_Name:
P-glycoprotein 1 inhibitors

First Approval Country :
Singapore

First Approval Date Filter:
2019

Origin Company_Name :
Hanmi Pharmaceutical Co Ltd

Active Company_Name :
Athenex Inc

Active Indication_Name:
Breast Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
Phase 1 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
GSDMD Antibody Data Sheet
Aducanumab manufacturer
RSK3 Antibody: RSK3 Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 83 kDa, targeting to RSK3. It can be used for WB,IHC-F,IHC-P,ICC/IF,IP assays with tag free, in the background of Human, Hamster.

Author: Betaine hydrochloride

Related Posts